Global Cardiovascular Devices Market Size & Trends Report Segmented by Product Type (Diagnostics & Monitoring Devices, Therapeutics & Surgical Devices), End User (Hospitals, Specialty Clinics) & Regional Forecast to 2030
The cardiovascular devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving growth include increased prevalence of cardiovascular diseases (CVDs), rising demand for minimally invasive procedures, growing aging population, advancement in medical technology, and rising awareness about cardiovascular health conditions. However, the market encounters certain challenges, including the high cost of cardiovascular devices limiting accessibility in low-income regions, stringent regulatory approvals and compliance requirements, and risk associated with device failure and complications during surgical interventions. To learn more about the research report, download a sample report.
Report Overview
Cardiovascular devices are medical devices and tools designed to diagnose, monitor, and treat diseases and conditions affecting the heart and blood vessels (cardiovascular system). These devices are used to manage various cardiovascular disorders, including heart disease, arrhythmias, heart failure, and vascular abnormalities. These devices play a crucial role in improving patient outcomes and quality of life by enabling early detection, effective treatment, and continuous care for cardiovascular conditions.
To learn more about this report, download the PDF brochure
Growing demand for minimally invasive cardiac procedures drives market growth
Minimally invasive cardiac procedures have transformed heart surgery by providing patients with safer and less invasive alternatives to traditional open-heart surgery. The adoption of these techniques is rapidly increasing, driven by the goals of minimizing patient trauma, reducing recovery times, and lowering healthcare costs. Procedures such as cardiac catheterization and percutaneous coronary intervention are becoming more prevalent due to their significant advantages over conventional methods. These techniques rely on specialized cardiology devices, including catheters, stents, and guidewires, which are experiencing growing demand. Additionally, minimally invasive approaches are widely utilized in a variety of cardiac surgeries, such as mitral valve repair, coronary artery bypass grafting, and aortic valve replacement, further fueling the demand for cardiovascular devices in the market.
Advancements in digital health technologies fuel its demand in the market
The integration of digital health technologies is transforming cardiology, particularly in the diagnosis, treatment, and management of cardiovascular diseases (CVDs). Rapid advancements in wearable devices, artificial intelligence (AI), and telemedicine are enabling more precise, predictive, and personalized care strategies, reshaping the landscape of cardiovascular health. Wearable technologies, such as smartwatches with electrocardiogram (ECG) capabilities, have enhanced early detection of arrhythmias, including atrial fibrillation (AF), improving patient outcomes through timely interventions. Similarly, AI-driven diagnostic tools and machine learning (ML) models are achieving higher accuracy in interpreting ECGs and detecting complex arrhythmias, often surpassing traditional methods. Telehealth has also surged in popularity, especially during the COVID-19 pandemic, by enabling remote monitoring of chronic CVDs. Devices such as implantable pacemakers and defibrillators have further reduced mortality rates by delivering real-time data to healthcare providers, facilitating early and effective interventions.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global cardiovascular devices market is marked by the presence of established and emerging market players such as Abbott Laboratories; GE HealthCare; Edwards Lifesciences Corporation; W. L. Gore & Associates, Inc.; Siemens Healthineers; BIOTRONIK SE & Co. KG; Terumo Corporation; Johnson & Johnson; Penumbra, Inc.; Philips Healthcare; Canon Medical Systems Asia Pte. Ltd.; B. Braun SE; LivaNova PLC; Cardinal Health; Medtronic; Boston Scientific Corporation among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | ~7% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product Type and End User |
| Regional Scope |
|
| Key Companies Mapped | Abbott Laboratories; GE HealthCare; Edwards Lifesciences Corporation; W. L. Gore & Associates, Inc.; Siemens Healthineers; BIOTRONIK SE & Co. KG; Terumo Corporation; Johnson & Johnson; Penumbra, Inc.; Philips Healthcare; Canon Medical Systems Asia Pte. Ltd.; B. Braun SE; LivaNova PLC; Cardinal Health; Medtronic; Boston Scientific Corporation |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Cardiovascular Devices Market Segmentation
This report by Medi-Tech Insights provides the size of the global cardiovascular devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type and end user.
Market Size & Forecast (2023-2030), By Product Type, USD Million
- Diagnostics & Monitoring Devices
- ECG
- Holter Monitors
- Event Monitors
- Implantable Cardiac Monitor
- Echocardiogram
- PET Scanner
- MRI
- Cardiac CT
- Cardiac Diagnostics Catheters
- Cardiovascular Ultrasound
- Others
- Therapeutic and Surgical Devices
- Pacemakers
- Implantable Cardioverter Defibrillators (ICDs)
- Coronary Stents
- Catheters and accessories
- Guidewires
- Cannula
- Electrosurgical Procedures
- Valves
- Occlusion Devices
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Clinics
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the cardiovascular devices market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the cardiovascular devices market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Cardiovascular Devices Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increased prevalence of cardiovascular diseases (CVDs)
- Rising demand for minimally invasive procedures
- Gowing aging population
- Advancement in medical technology
- Rising awareness about cardiovascular health conditions
- Restraints
- High cost of cardiovascular devices, limiting accessibility in low-income regions
- Stringent regulatory approvals and compliance requirements
- Risks of device failure and complications during surgical interventions
- Opportunities
- Expansion of telemedicine and remote monitoring
- Growth in emerging markets
- Integration of AI algorithms to enhance device performance and diagnostics
- Key Market Trends
- Development of bioresorbable stents and advanced drug-eluting stents
- Growing focus on preventive healthcare
- Adoption of wearable cardiac monitoring devices for real-time data tracking
- Unmet Market Needs
- Industry Speaks
- Global Cardiovascular Devices Market Size & Forecast (2023-2030), By Product Type, USD Million
- Introduction
- Diagnostics & Monitoring Devices
- ECG
- Holter Monitors
- Event Monitors
- Implantable Cardiac Monitor
- Echocardiogram
- PET Scanner
- MRI
- Cardiac CT
- Cardiac Diagnostics Catheters
- Cardiovascular Ultrasound
- Others
- Therapeutic and Surgical Devices
- Pacemakers
- Implantable Cardioverter Defibrillators (ICDs)
- Coronary Stents
- Catheters and accessories
- Guidewires
- Cannula
- Electrosurgical Procedures
- Valves
- Occlusion Devices
- Others
- Global Cardiovascular Devices Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals
- Clinics
- Others
- Global Cardiovascular Devices Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Cardiovascular Devices Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Cardiovascular Devices Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Cardiovascular Devices Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Cardiovascular Devices Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Cardiovascular Devices Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Abbott Laboratories
- GE HealthCare
- Edwards Lifesciences Corporation
- L. Gore & Associates, Inc.
- Siemens Healthineers
- BIOTRONIK SE & Co. KG
- LivaNova PLC
- Cardinal Health
- Medtronic
- Boston Scientific Corporation
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Speciality Clinics, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts.
Data Triangulation
Research findings derived through secondary sources & internal analysis were validated with Primary Interviews, the Internal Knowledge Repository, and Company’s Sales Data.
